Akari Therapeutics Plc (AKTX)
7.52
-0.33
(-4.20%)
USD |
NASDAQ |
Aug 24, 16:00
7.52
0.00 (0.00%)
After-Hours: 20:00
Akari Therapeutics Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| DBV Technologies SA | -- |
| Cellectis SA | 15.62% |
| argenx SE | -- |
| Autolus Therapeutics Plc | 55.20% |
| Evaxion AS | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -141.0% |
| Return on Assets | -71.26% |
| Return on Invested Capital | -133.8% |
| Return on Net Operating Assets | -79.10% |